Modulation of the fecal bile acid profile by gut microbiota in cirrhosis
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background and Aims The 7α-dehydroxylation of primary bile acids (BAs), chenodeoxycholic (CDCA) and cholic acid (CA) into the secondary BAs, lithocholic (LCA) and deoxycholic acid (DCA) is a key function of the gut microbiota. We aimed to study the linkage between fecal BAs and gut microbiota in cirrhosis since this could help understand cirrhosis progression. Methods Fecal microbiota were analyzed by culture-independent multitagged-pyrosequencing, fecal BAs using HPLC and serum BAs using LC-MS in controls, early (Child A), and advanced cirrhotics(Child B/C). A subgroup of early cirrhotics underwent BA and microbiota analysis before/after eight weeks of rifaximin. Results Cross-sectional: 47 cirrhotics(24 advanced) and 14 controls were included. In feces, advanced cirrhotics had the lowest total, secondary, secondary/primary BA ratios, and highest primary BAs compared to early cirrhotics and controls. Secondary fecal BAs were detectable in all controls but in a significantly lower proportion of cirrhotics (p<0.002). Serum primary BAs were higher in advanced cirrhotics compared to the rest. Cirrhotics, compared to controls, had a higher Enterobacteriaceae (potentially pathogenic) but lower Lachonospiraceae, Ruminococcaceae and Blautia (7α-dehydroxylating bacteria) abundance. CDCA was positively correlated with Enterobacteriaceae(r=0.57, p<0.008) while Ruminococcaceae were positively correlated with DCA(r=0.4, p<0.05). A positive correlation between Ruminococcaceae and DCA/CA (r=0.82, p<0.012) and Blautia with LCA/CDCA (r=0.61, p<0.03) was also seen. Prospective study: Post-rifaximin, six early cirrhotics had reduction in Veillonellaceae and in the secondary/primary BA ratios. Conclusions Cirrhosis, especially advanced disease, is associated with a decreased conversion of primary to secondary fecal BAs which is linked with abundance of key gut microbiome taxa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Self-citationDietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904
Rifaximin Treatment in Hepatic Encephalopathy
Bass, N. M., Mullen, K. D., Sanyal, A., Poordad, F., Neff, G., Leevy, C. B., Sigal, S., Sheikh, M. Y., Beavers, K., Frederick, T., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907893 · Cited by 1,300
Characterization of fecal microbial communities in patients with liver cirrhosis
Chen, Y., Yang, F., Lu, H., Wang, B., Chen, Y., Lei, D., Wang, Y., Zhu, B., & Li, L. (2011) · Hepatology · doi:10.1002/hep.24423 · Cited by 1,038
Bile Acid Is a Host Factor That Regulates the Composition of the Cecal Microbiota in Rats
Islam, K. B. M. S., Fukiya, S., Hagio, M., Fujii, N., Ishizuka, S., Ooka, T., Ogura, Y., Hayashi, T., & Yokota, A. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.046 · Cited by 918
Systemic gut microbial modulation of bile acid metabolism in host tissue compartments
Swann, J. R., Want, E. J., Geier, F. M., Spagou, K., Wilson, I. D., Sidaway, J. E., Nicholson, J. K., & Holmes, E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006734107 · Cited by 726 · cited 2×
“Apart from their digestive role, bile acids can influence the intestinal milieu, the integrity of the mucosal barrier, and the synthesis of anti-bacterial peptides and lectins [6,7].”
Liu, Q., Duan, Z. P., Ha, D. K., Bengmark, S., Kurtovic, J., & Riordan, S. M. (2004) · Hepatology · doi:10.1002/hep.20194 · Cited by 638
Bacterial Infections, Sepsis, and Multiorgan Failure in Cirrhosis
Tandon, P., & Garcia-Tsao, G. (2008) · Seminars in Liver Disease · doi:10.1055/s-2008-1040319 · Cited by 551
Linkage of gut microbiome with cognition in hepatic encephalopathy
Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2011 · Cited by 547 · cited 12×
“Correlation between stool BAs and microbiome The fecal primary BA, CDCA, was significantly positively correlated with Enterobacteriaceae (r = 0.57, p = 0.008) and negatively with Bacterioidaceae (r = 0.5, p = 0.026) abundance.”
InfluentialSelf-citationBajaj, J. S., Hylemon, P. B., Ridlon, J. M., Heuman, D. M., Daita, K., White, M. B., Monteith, P., Noble, N. A., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00152.2012 · Cited by 527
Self-citation
Cited by
Introduction to the human gut microbiota
Thursby, E., & Juge, N. (2017) · Biochemical Journal · doi:10.1042/bcj20160510 · Cited by 3,600
The gut-liver axis in liver disease: Pathophysiological basis for therapy
Albillos, A., de Gottardi, A., & Rescigno, M. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.10.003 · Cited by 2,166
Blautia —a new functional genus with potential probiotic properties?
Liu, X., Mao, B., Gu, J., Wu, J., Cui, S., Wang, G., Zhao, J., Zhang, H., & Chen, W. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1875796 · Cited by 1,381
Bile acids and the gut microbiome
Ridlon, J. M., Kang, D. J., Hylemon, P. B., & Bajaj, J. S. (2014) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000057 · Cited by 1,329
Self-citationLiver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237
“Moreover, highlighting the reciprocal interaction of bile acids and the gut microbiome, reduced excretion of primary bile acids in liver fibrosis with compromised liver function directly affects composition of the gut microbiome [119,121].”
BackgroundLoomba, R., Seguritan, V., Li, W., Long, T., Klitgord, N., Bhatt, A., Dulai, P. S., Caussy, C., Bettencourt, R., Highlander, S. K., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.001 · Cited by 1,123
Altered profile of human gut microbiome is associated with cirrhosis and its complications
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., White, M. B., Monteith, P., Noble, N. A., Unser, A. B., Daita, K., Fisher, A. R., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.019 · Cited by 1,099
“We found in our prior studies that cirrhosis and HE were accompanied by reduced relative abundance of taxa considered benign and autochthonous, including Lachnospiraceae, Ruminococcaceae, and Clostridialies Incertae Sedis XIV (from now on called Clostridialies XIV) and a relatively higher abundance of others, particul…”
Self-citationGut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Aron-Wisnewsky, J., Vigliotti, C., Witjes, J., Le, P., Holleboom, A. G., Verheij, J., Nieuwdorp, M., & Clément, K. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-0269-9 · Cited by 1,063
Interactions Between the Intestinal Microbiome and Liver Diseases
Schnabl, B., & Brenner, D. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.01.020 · Cited by 971
Bile acid signaling in metabolic disease and drug therapy
Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935
“Bacterial dysbiosis has been associated with IBDs, obesity, type 2 diabetes mellitus (T2DM), nonalcoholic fatty liver disease (NAFLD), liver cirrhosis, and cancer (Kakiyama et al., 2013; Ridlon et al., 2013, 2014; Duseja and Chawla, 2014; Joyce and Gahan, 2014).”
BackgroundDysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation
Sinha, S. R., Haileselassie, Y., Nguyen, L. P., Tropini, C., Wang, M., Becker, L. S., Sim, D., Jarr, K., Spear, E. T., Singh, G., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.021 · Cited by 852
Gut-liver axis: Pathophysiological concepts and clinical implications
Tilg, H., Adolph, T. E., & Trauner, M. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.017 · Cited by 843
The gut–liver axis and gut microbiota in health and liver disease
Hsu, C. L., & Schnabl, B. (2023) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00904-3 · Cited by 737
Alcohol, liver disease and the gut microbiota
Bajaj, J. S. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0099-1 · Cited by 697
Self-citationIntestinal transport and metabolism of bile acids
Dawson, P. A., & Karpen, S. J. (2015) · Journal of Lipid Research · doi:10.1194/jlr.r054114 · Cited by 598
Diversification of host bile acids by members of the gut microbiota
Winston, J. A., & Theriot, C. M. (2020) · Gut Microbes · doi:10.1080/19490976.2019.1674124 · Cited by 587
Interaction of gut microbiota with bile acid metabolism and its influence on disease states
Staley, C., Weingarden, A. R., Khoruts, A., & Sadowsky, M. J. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-016-8006-6 · Cited by 581
Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy
Chiang, J. Y. L., & Ferrell, J. M. (2020) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00223.2019 · Cited by 580
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
Llopis, M., Cassard, A. M., Wrzosek, L., Boschat, L., Bruneau, A., Ferrere, G., Puchois, V, Martin, J. C., Lepage, P., Le Roy, T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310585 · Cited by 560
Milosevic, I., Vujovic, A., Barac, A., Djelic, M., Korac, M., Radovanovic Spurnic, A., Gmizic, I., Stevanovic, O., Djordjevic, V., Lekic, N., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020395 · Cited by 551
“GM dysbiosis in NAFLD could affect the conversion of primary bile acids into secondary bile acids [42].”
BackgroundIntestinal Barrier in Human Health and Disease
Di Tommaso, N., Gasbarrini, A., & Ponziani, F. R. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182312836 · Cited by 533
Mailing, L. J., Allen, J. M., Buford, T. W., Fields, C. J., & Woods, J. A. (2019) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000183 · Cited by 521
Ford, A. C., Mahadeva, S., Carbone, M. F., Lacy, B. E., & Talley, N. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30469-4 · Cited by 517
Theriot, C. M., Bowman, A. A., & Young, V. B. (2016) · mSphere · doi:10.1128/msphere.00045-15 · Cited by 481
“This is consistent with another study in which blooms of proinflammatory Enterobacteriaceae were found in cirrhotic patients and corresponded with a decrease in fecal bile acid levels (52).”
ResultHepatic encephalopathy: Novel insights into classification, pathophysiology and therapy
Rose, C. F., Amodio, P., Bajaj, J. S., Dhiman, R. K., Montagnese, S., Taylor-Robinson, S. D., Vilstrup, H., & Jalan, R. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.07.013 · Cited by 470
Self-citationBile acids in glucose metabolism in health and disease
Shapiro, H., Kolodziejczyk, A. A., Halstuch, D., & Elinav, E. (2018) · Journal of Experimental Medicine · doi:10.1084/jem.20171965 · Cited by 464
Interactions between Bacteria and Bile Salts in the Gastrointestinal and Hepatobiliary Tracts
Urdaneta, V., & Casadesús, J. (2017) · Frontiers in Medicine · doi:10.3389/fmed.2017.00163 · Cited by 449
Gut–liver axis: barriers and functional circuits
Pabst, O., Hornef, M. W., Schaap, F. G., Cerovic, V., Clavel, T., & Bruns, T. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00771-6 · Cited by 436
Blautia genus associated with visceral fat accumulation in adults 20–76 years of age
Ozato, N., Saito, S., Yamaguchi, T., Katashima, M., Tokuda, I., Sawada, K., Katsuragi, Y., Kakuta, M., Imoto, S., Ihara, K., et al. (2019) · npj Biofilms and Microbiomes · doi:10.1038/s41522-019-0101-x · Cited by 416
The dormant blood microbiome in chronic, inflammatory diseases
Potgieter, M., Bester, J., Kell, D. B., & Pretorius, E. (2015) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv013 · Cited by 383
Wang, B., Jiang, X., Cao, M., Ge, J., Bao, Q., Tang, L., Chen, Y., & Li, L. (2016) · Scientific Reports · doi:10.1038/srep32002 · Cited by 376
Gut–organ axis: a microbial outreach and networking
Ahlawat, S., Asha, & Sharma, K. K. (2021) · Letters in Applied Microbiology · doi:10.1111/lam.13333 · Cited by 361
The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases
Baldelli, V., Scaldaferri, F., Putignani, L., & Del Chierico, F. (2021) · Microorganisms · doi:10.3390/microorganisms9040697 · Cited by 350
Nho, K., Kueider‐Paisley, A., MahmoudianDehkordi, S., Arnold, M., Risacher, S. L., Louie, G., Blach, C., Baillie, R., Han, X., Kastenmüller, G., et al. (2019) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.08.012 · Cited by 343
Cirrhosis, bile acids and gut microbiota: Unraveling a complex relationship
Ridlon, J. M., Alves, J. M., Hylemon, P. B., & Bajaj, J. S. (2013) · Gut Microbes · doi:10.4161/gmic.25723 · Cited by 336
Self-citationSalivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy
Bajaj, J. S., Betrapally, N. S., Hylemon, P. B., Heuman, D. M., Daita, K., White, M. B., Unser, A., Thacker, L. R., Sanyal, A. J., Kang, D. J., et al. (2015) · Hepatology · doi:10.1002/hep.27819 · Cited by 325
“The presence of these bacteria in the stool in these studies is likely an epiphenomenon of impaired bile and gastric acid output in cirrhosis.(6,7,23) Our results are novel because they directly measure bacterial presence in the saliva of patients with cirrhosis and then relate them to stool bacteria.”
ResultSelf-citationLean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation
Chen, F., Esmaili, S., Rogers, G. B., Bugianesi, E., Petta, S., Marchesini, G., Bayoumi, A., Metwally, M., Azardaryany, M. K., Coulter, S., et al. (2020) · Hepatology · doi:10.1002/hep.30908 · Cited by 327
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice
Ferrere, G., Wrzosek, L., Cailleux, F., Turpin, W., Puchois, V., Spatz, M., Ciocan, D., Rainteau, D., Humbert, L., Hugot, C., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.11.008 · Cited by 324
Bile acid is a significant host factor shaping the gut microbiome of diet-induced obese mice
Zheng, X., Huang, F., Zhao, A., Lei, S., Zhang, Y., Xie, G., Chen, T., Qu, C., Rajani, C., Dong, B., et al. (2017) · BMC Biology · doi:10.1186/s12915-017-0462-7 · Cited by 323
“duce the more anti-microbial secondary BAs from primary BAs [14].”
Molecular Pathogenesis of Cholangiocarcinoma
Labib, P. L., Goodchild, G., & Pereira, S. P. (2019) · BMC Cancer · doi:10.1186/s12885-019-5391-0 · Cited by 310
Management of the critically ill patient with cirrhosis: A multidisciplinary perspective
Nadim, M. K., Durand, F., Kellum, J. A., Levitsky, J., O’Leary, J. G., Karvellas, C. J., Bajaj, J. S., Davenport, A., Jalan, R., Angeli, P., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.019 · Cited by 297
Self-citationBile acid metabolism and signaling in liver disease and therapy
Chiang, J. Y. L. (2017) · Liver Research · doi:10.1016/j.livres.2017.05.001 · Cited by 294
Gut liver brain axis in diseases: the implications for therapeutic interventions
Yan, M., Man, S., Sun, B., Ma, L., Guo, L., Huang, L., & Gao, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01673-4 · Cited by 287
Alcoholic Liver Disease: The Gut Microbiome and Liver Cross Talk
Hartmann, P., Seebauer, C. T., & Schnabl, B. (2015) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12704 · Cited by 282
Bajaj, J. S., Heuman, D. M., Hylemon, P. B., Sanyal, A. J., Puri, P., Sterling, R. K., Luketic, V., Stravitz, R. T., Siddiqui, M. S., Fuchs, M., et al. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12695 · Cited by 274
Self-citationRelationship between gut microbiota and circulating metabolites in population-based cohorts
Vojinovic, D., Radjabzadeh, D., Kurilshikov, A., Amin, N., Wijmenga, C., Franke, L., Ikram, M. A., Uitterlinden, A. G., Zhernakova, A., Fu, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13721-1 · Cited by 271
Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease
Hegyi, P., Maléth, J., Walters, J. R., Hofmann, A. F., & Keely, S. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00054.2017 · Cited by 269
The microbiota in cirrhosis and its role in hepatic decompensation
Trebicka, J., Macnaughtan, J., Schnabl, B., Shawcross, D. L., & Bajaj, J. S. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.11.013 · Cited by 268
Self-citationLv, L., Fang, D., Shi, D., Chen, D., Yan, R., Zhu, Y., Chen, Y., Shao, L., Guo, F., Wu, W., et al. (2016) · Environmental Microbiology · doi:10.1111/1462-2920.13401 · Cited by 245
Microbial impact on cholesterol and bile acid metabolism: current status and future prospects
Kriaa, A., Bourgin, M., Potiron, A., Mkaouar, H., Jablaoui, A., Gérard, P., Maguin, E., & Rhimi, M. (2019) · Journal of Lipid Research · doi:10.1194/jlr.r088989 · Cited by 264
Dietary fat, bile acid metabolism and colorectal cancer
Ocvirk, S., & O’Keefe, S. J. D. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.003 · Cited by 262
The gut microbiota: A treasure for human health
Li, D., Wang, P., Wang, P., Hu, X., & Chen, F. (2016) · Biotechnology Advances · doi:10.1016/j.biotechadv.2016.08.003 · Cited by 261
Microbiota, cirrhosis, and the emerging oral-gut-liver axis
Acharya, C., Sahingur, S. E., & Bajaj, J. S. (2017) · JCI Insight · doi:10.1172/jci.insight.94416 · Cited by 256
Self-citationLelouvier, B., Servant, F., Païssé, S., Brunet, A., Benyahya, S., Serino, M., Valle, C., Ortiz, M. R., Puig, J., Courtney, M., et al. (2016) · Hepatology · doi:10.1002/hep.28829 · Cited by 242
“Altogether, these data demonstrate that the gut microbiota was impacted in patients with LF similarly to observations reported by other groups studying related liver diseases.((24-27)) A”
BackgroundResultCaussy, C., Hsu, C., Lo, M., Liu, A., Bettencourt, R., Ajmera, V. H., Bassirian, S., Hooker, J., Sy, E., Richards, L., et al. (2018) · Hepatology · doi:10.1002/hep.29892 · Cited by 205
“Reduced bacterial diversity in NAFLD patients has been associated with disrupted bile acids profiles in serum and feces, potentially due to the loss of gut microbiota members involved in the generation of secondary bile acids.((40)) In addition, certain species of the gut”
BackgroundYounes, R., Govaere, O., Petta, S., Miele, L., Tiniakos, D., Burt, A., David, E., Vecchio, F. M., Maggioni, M., Cabibi, D., et al. (2022) · Gut · doi:10.1136/gutjnl-2020-322564 · Cited by 205
Catry, E., Bindels, L. B., Tailleux, A., Lestavel, S., Neyrinck, A. M., Goossens, J.-F., Lobysheva, I., Plovier, H., Essaghir, A., Demoulin, J.-B., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313316 · Cited by 194
Ohtani, N., & Kawada, N. (2019) · Hepatology Communications · doi:10.1002/hep4.1331 · Cited by 187
“(63,64) DCA may influence early stage liver cirrhosis when 7α-dehydroxylating (DCA producing) bacteria, such as Lachonospiraceae and Ruminococcaceae, are fairly abundant(60); these bacteria have been shown to be greatly decreased in the decompensated stage of cirrhosis.(60,65) The excessive intake of an HFD increases…”
BackgroundMa, J., Hong, Y., Zheng, N., Xie, G., Lyu, Y., Gu, Y., Xi, C., Chen, L., Wu, G., Li, Y., et al. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1763770 · Cited by 171
Gut dysbiosis associated with hepatitis C virus infection
Inoue, T., Nakayama, J., Moriya, K., Kawaratani, H., Momoda, R., Ito, K., Iio, E., Nojiri, S., Fujiwara, K., Yoneda, M., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy205 · Cited by 183
The interaction between smoking, alcohol and the gut microbiome
Capurso, G., & Lahner, E. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.10.006 · Cited by 182
Aoki, R., Onuki, M., Hattori, K., Ito, M., Yamada, T., Kamikado, K., Kim, Y.-G., Nakamoto, N., Kimura, I., Clarke, J. M., et al. (2021) · Microbiome · doi:10.1186/s40168-021-01125-7 · Cited by 167
“files of the bile acids, 3-(4-hydroxyphenyl)lactate and phenylacetic acid [6, 7, 11, 12].”
BackgroundChen, W., Wei, Y., Xiong, A., Li, Y., Guan, H., Wang, Q., Miao, Q., Bian, Z., Xiao, X., Lian, M., et al. (2020) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-019-08731-2 · Cited by 166
The features of mucosa‐associated microbiota in primary sclerosing cholangitis
Torres, J., Bao, X., Goel, A., Colombel, J. ‐., Pekow, J., Jabri, B., Williams, K. M., Castillo, A., Odin, J. A., Meckel, K., et al. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13552 · Cited by 149
Bajaj, J. S., Idilman, R., Mabudian, L., Hood, M., Fagan, A., Turan, D., White, M. B., Karakaya, F., Wang, J., Atalay, R., et al. (2018) · Hepatology · doi:10.1002/hep.29791 · Cited by 125
Self-citationPromises of microbiome-based therapies
Bajaj, J. S., Ng, S. C., & Schnabl, B. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.12.003 · Cited by 119
Self-citationGut microbiota, cirrhosis, and alcohol regulate bile acid metabolism in the gut
Ridlon, J. M., Kang, D.-J., Hylemon, P. B., & Bajaj, J. S. (2015) · Digestive Diseases · doi:10.1159/000371678 · Cited by 109
Self-citationWise, J. L., & Cummings, B. P. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1093420 · Cited by 94
“The importance of this bidirectional relationship is further highlighted by research showing that gut bacterial bile acid metabolic potential is a key determinant of whether an FMT treatment will effectively colonize the host (Kakiyama et al., 2013; Ng et al., 2020).”
BackgroundThe dynamics of the bacterial communities developed in maize silage
Gharechahi, J., Kharazian, Z. A., Sarikhan, S., Jouzani, G. S., Aghdasi, M., & Hosseini Salekdeh, G. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12751 · Cited by 89
“In human, bile acids appear to play a critical role in regulating gut microbiota composition (Kakiyama et al., 2013; Ridlon et al., 2014).”
BackgroundGut-liver axis: Recent concepts in pathophysiology in alcohol-associated liver disease
Raya Tonetti, F., Eguileor, A., Mrdjen, M., Pathak, V., Travers, J., Nagy, L. E., & Llorente, C. (2024) · Hepatology · doi:10.1097/hep.0000000000000924 · Cited by 78
Immunoglobulin A and liver diseases
Inamine, T., & Schnabl, B. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-017-1400-8 · Cited by 76
Pataky, Z., Genton, L., Spahr, L., Lazarevic, V., Terraz, S., Gaïa, N., Rubbia-Brandt, L., Golay, A., Schrenzel, J., & Pichard, C. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4179-1 · Cited by 75
“Lower levels of Lachnospiraceae and Ruminococcaceae, belonging to the Firmicutes phylum, were also described in cirrhotic patients compared to healthy controls [39, 40].”
BackgroundTrimethylamine-N-oxide: a link between the gut microbiome, bile acid metabolism, and atherosclerosis
Wilson, A., McLean, C., & Kim, R. B. (2016) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000274 · Cited by 71
Targeting nonalcoholic fatty liver disease via gut microbiome-centered therapies
Koning, M., Herrema, H., Nieuwdorp, M., & Meijnikman, A. S. (2023) · Gut Microbes · doi:10.1080/19490976.2023.2226922 · Cited by 56
“The levels of bile acids in the blood and feces differ in various stages of NAFLD and in end-stage liver disease, the total bile acid pool is reduced and with lower formation of secondary bile acids.(110,111) The relation between secondary bile 8 M.”
BackgroundAdvances in Gut Microbiota of Viral Hepatitis Cirrhosis
Wang, Y., Pan, C. Q., & Xing, H. (2019) · BioMed Research International · doi:10.1155/2019/9726786 · Cited by 52
Gut microbial profile in biliary atresia: a case‐control study
Wang, J., Qian, T., Jiang, J., Yang, Y., Shen, Z., Huang, Y., Chen, G., Zheng, S., & Dong, R. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14777 · Cited by 51
The Human Gut Microbiome in Liver Diseases
Davis, B., & Bajaj, J. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1602763 · Cited by 34
Self-citationZhao, S., Fu, H., Zhou, T., Cai, M., Huang, Y., Gan, Q., Zhang, C., Qian, C., Wang, J., Zhang, Z., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.772368 · Cited by 26
Gut microbial profile of treatment-naive patients with primary biliary cholangitis
Zhou, Y.-J., Ying, G.-X., Dong, S.-L., Xiang, B., & Jin, Q.-F. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1126117 · Cited by 26
“Ruminococcaceae plays an important role in the conversion of primary bile acids into secondary bile acids (33), and impaired production of secondary bile acids can cause dysbiosis of gut microbiota and induce intestinal inflammation (34).”
Background
Metadata
- Authors
- Kakiyama, G., Pandak, W. M., Gillevet, P. M., Hylemon, P. B., Heuman, D. M., Daita, K., Takei, H., Muto, A., Nittono, H., Ridlon, J. M., White, M. B., Noble, N. A., Monteith, P., Fuchs, M., Thacker, L. R., Sikaroodi, M., & Bajaj, J. S.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-05
- Volume
- 58
- Issue
- 5
- Pages
- 949-955
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2018274907
- Cited by
- 781
- References
- 26
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.